These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 15457440)
1. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Zouali M; Sarmay G Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440 [No Abstract] [Full Text] [Related]
2. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway. Cornall RJ; Goodnow CC; Cyster JG Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649 [No Abstract] [Full Text] [Related]
3. Lyn/CD22/SHP-1 and their importance in autoimmunity. Blasioli J; Goodnow CC Curr Dir Autoimmun; 2002; 5():151-60. PubMed ID: 11826756 [No Abstract] [Full Text] [Related]
4. B cell inhibitory receptors and autoimmunity. Pritchard NR; Smith KG Immunology; 2003 Mar; 108(3):263-73. PubMed ID: 12603592 [No Abstract] [Full Text] [Related]
5. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Fearon DT; Carroll MC Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064 [TBL] [Abstract][Full Text] [Related]
6. B lymphocytes are required for development and treatment of autoimmune diseases. Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517 [TBL] [Abstract][Full Text] [Related]
7. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639 [TBL] [Abstract][Full Text] [Related]
8. Signaling mutations and autoimmunity. Yu CC; Mamchak AA; DeFranco AL Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047 [TBL] [Abstract][Full Text] [Related]
9. Signal transduction via the B-cell antigen receptor: the role of protein tyrosine kinases and protein tyrosine phosphatases. Justement LB Curr Top Microbiol Immunol; 2000; 245(1):1-51. PubMed ID: 10533309 [No Abstract] [Full Text] [Related]
10. Human killer inhibitory receptors: specificity for HLA-class I molecules and mechanisms of signal transduction. Colonna M; Döhring C; Samaridis J; Scheidegger D; Dessing M; Cella M; Campbell KS Transplant Proc; 1996 Dec; 28(6):3035. PubMed ID: 8962177 [No Abstract] [Full Text] [Related]
11. Expression of B cell receptor-associated signaling molecules in human lupus. Huck S; Le Corre R; Youinou P; Zouali M Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380 [TBL] [Abstract][Full Text] [Related]
12. [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version]. Tsubata T Z Rheumatol; 2016 Feb; 75(1):86-9. PubMed ID: 26830296 [No Abstract] [Full Text] [Related]
13. Activation of self-reactive B cells and autoimmune diseases. Burrows PD; Suematsu S; Watanabe T Rev Immunogenet; 2000; 2(1):38-51. PubMed ID: 11324692 [TBL] [Abstract][Full Text] [Related]
14. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237 [TBL] [Abstract][Full Text] [Related]
15. Co-receptors on B lymphocytes. Tsubata T Curr Opin Immunol; 1999 Jun; 11(3):249-55. PubMed ID: 10375550 [TBL] [Abstract][Full Text] [Related]
16. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22. Fearon DT Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972 [No Abstract] [Full Text] [Related]
18. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Tedder TF; Tuscano J; Sato S; Kehrl JH Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697 [TBL] [Abstract][Full Text] [Related]
19. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654 [TBL] [Abstract][Full Text] [Related]
20. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Doody GM; Justement LB; Delibrias CC; Matthews RJ; Lin J; Thomas ML; Fearon DT Science; 1995 Jul; 269(5221):242-4. PubMed ID: 7618087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]